Journal Article
. 2020 Jun; 11:979.
doi: 10.3389/fimmu.2020.00979.

Plasma Cells in the Melanoma Tumor Microenvironment-Mechanistic Roles for IgA

Rakesh Verma 1 Lalit Kumar 2 
  • PMID: 32582154
  •     14 References
  •     1 citations

No abstract available

Keywords: IgA; PD1; biomarker; checkpoint blockade; immune therapies; plasma cells; tumor microenvironment.

Plasma cells within the infiltrate of primary cutaneous malignant melanoma of the skin. A confirmation of its histoprognostic value.
J M Mascaro, M Molgo, T Castel, J Castro.
Am J Dermatopathol, 1987 Dec 01; 9(6). PMID: 3445926
Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.
Michael D Iglesia, Benjamin G Vincent, +4 authors, Jonathan S Serody.
Clin Cancer Res, 2014 Jun 12; 20(14). PMID: 24916698    Free PMC article.
Highly Cited.
IgA as a blocking factor in human malignant melanoma.
P A O'Neill, M M Romsdahl.
Immunol Commun, 1974 Jan 01; 3(5). PMID: 4214759
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
Michael D Iglesia, Joel S Parker, +3 authors, Benjamin G Vincent.
J Natl Cancer Inst, 2016 Jun 24; 108(11). PMID: 27335052    Free PMC article.
Highly Cited.
Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma.
Amy Frankenthaler, Ryan J Sullivan, +4 authors, Michael B Atkins.
Melanoma Res, 2010 Sep 09; 20(6). PMID: 20823779
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.
Rituparna Das, Rakesh Verma, +8 authors, Kavita M Dhodapkar.
J Immunol, 2014 Dec 30; 194(3). PMID: 25539810    Free PMC article.
Highly Cited.
Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?
Jean-Luc Teillaud, Marie-Caroline Dieu-Nosjean.
Front Immunol, 2017 Aug 09; 8. PMID: 28785261    Free PMC article.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer.
Miriam Lohr, Karolina Edlund, +14 authors, Patrick Micke.
Cancer Lett, 2013 Feb 02; 333(2). PMID: 23370224
Ipilimumab: a promising immunotherapy for melanoma.
Jaykumar R Thumar, Harriet M Kluger.
Oncology (Williston Park), 2011 Feb 08; 24(14). PMID: 21294471
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.
Claire Germain, Sacha Gnjatic, Marie-Caroline Dieu-Nosjean.
Front Immunol, 2015 Mar 11; 6. PMID: 25755654    Free PMC article.
Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.
Francesca M Bosisio, James S Wilmott, +9 authors, Joost J van den Oord.
Mod Pathol, 2016 Feb 13; 29(4). PMID: 26867783
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
Manish J Butte, Mary E Keir, +2 authors, Gordon J Freeman.
Immunity, 2007 Jul 17; 27(1). PMID: 17629517    Free PMC article.
Highly Cited.
The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
S M A Mahmoud, A H S Lee, +3 authors, A R Green.
Breast Cancer Res Treat, 2011 Jun 15; 132(2). PMID: 21671016
B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments.
Yuan Wei, Chun-Xiang Huang, +4 authors, Dong-Ming Kuang.
Oncogene, 2021 Jul 01; 40(29). PMID: 34188249